The trademark application ONCOFIND was filed by Exact Sciences Corporation, a U.S. corporation (the "Applicant"). The application was published for oppositions on March 24, 2022, and it was registered by office on July 1, 2022 without any oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 1 with following description of goods:
Reagents for research purposes in the field of cancer
Reagents for scientific or medical research use
Assays and reagents for use in genetic research.
The mark was filed in class 5 with following description of goods:
Cancer screening test comprised of molecular diagnostic reagents for detecting DNA, protein, methylation and/or chromosomal changes, abnormalities or mutations
Diagnostic test consisting of buffers and reagents for use in cancer testing
Reagents for medical use
Medical diagnostic reagents.
The mark was filed in class 10 with following description of goods:
Diagnostic apparatus for the detection of cancer and pre-cancer
Apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, liquid biopsy testing
Apparatus for collecting biological samples for use in the detection of cancer and pre-cancer for medical purposes
Containers for collecting biological samples for use in the detection of cancer and pre-cancer for medical purposes.